Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis
Identificadores
Identificadores
Fecha de publicación
2015Título de revista
DIGESTIVE DISEASES AND SCIENCES
Tipo de contenido
Artigo